CLDI — Calidi Biotherapeutics Inc.

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates CLDI Bearish with a Setup Score of 46, net conviction 43, actionability 50. How the Setup Score works →

Total Setup Score46
Directional BiasBearish
Net Conviction43
Actionability50 (in range)

Key signals behind this score

About Calidi Biotherapeutics Inc.

Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-40… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$0.48
Market Cap$1.7M
Float3.4M
Shares Outstanding3.4M
Price/Sales (TTM)50.83
vs. Analyst Target+24901.0% to analyst PT
Dividend RateNone
Analyst Target Price$120.00 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$7.9M N/A -$6.7M
2021 $449,000 -$10.9M $355,000 -$9.5M
2022 $45,000 -$25.4M -$229,000 -$25.0M
2023 N/A -$29.2M -$1.3M -$24.2M
2024 N/A -$22.1M -$1.5M -$19.7M
2025 N/A -$19.9M -$1.7M -$18.2M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Dec 2025 N/A -$4.1M
Mar 2026 N/A -$4.1M
Jun 2026 N/A -$4.2M
Sep 2026 N/A -$3.6M

Ownership & Float

Insider Ownership0.7%
Institutional Ownership5.3%
Short Float5.3%
% of All Funds Holding0.01%
Number of Funds Holding1

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$0.83Near-term / short-term trend
Weekly40-Week SMA$2.84Medium-term trend
Weekly80-Week SMA$23.37Cyclical trend (business cycle)
Weekly200-Week SMA$3785.95Secular trend (multi-year)
Monthly10-Month SMA$3.12Near-term monthly trend
Monthly20-Month SMA$24.22Medium-term monthly trend
Monthly40-Month SMA$1062.94Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$2.40 resistance 2.73x 3 months ago
$220.00 resistance 1.78x 21 months ago
$407.00 resistance 1.66x 22 months ago

Historical Earnings Reactions (19 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.48% 0.00% 36.84% 18.48% -12.67%
1 Day 5.75% 0.00% 42.11% 60.19% -6.18%
1 Week 2.51% 0.00% 44.44% 107.00% -24.73%
2 Weeks 3.54% 0.15% 55.56% 128.31% -68.86%
1 Month -11.79% -4.95% 50.00% 12.63% -67.47%

Next earnings: February 1, 2027 (70 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.84% 35.2% 236
Tuesday -0.02% 34.0% 262
Wednesday -0.33% 36.2% 260
Thursday -0.09% 36.1% 252
Friday -1.09% 33.1% 254

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 5.3%

Insider Transactions — Smart Summary

Total insider ownership: 0.7%

12-Month Insider Activity Summary

Total Filings1
Net Value+N/A
Net Shares Change-850
% of Float-0.0%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Camaisa Allan -$1,236.75 1 1 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-16 Camaisa Allan -$1,236.75 Transaction at $1.46, now -67.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Calidi Biotherapeutics Inc. (CLDI) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CLDI on Trend Edge →